menu search

Vig: a bet on the u.s. economy

Vanguard Dividend Appreciation ETF is a good option for new investors or those seeking safety and stability in a high-quality ETF. VIG has a blended <...

November 4, 2023, 2:58 am

Sedg investor alert: robbins geller rudman & dowd llp announces that solaredge technologies, inc. investors with substantial losses have opportunity to lead the solaredge class action lawsuit

SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of SolarEdge Technologies, Inc. ...

November 4, 2023, 2:55 am

Crypto news: opensea makes strategic changes as chiliz goes bigger in sports

NFTs were in focus on Friday, with OpenSea cutting its workforce in a bid to reboot. NFT trading volumes remain lackluster despite the crypto revival....

November 4, 2023, 2:41 am

The bottom fishing club: pbf energy

PBF Energy has a stellar balance sheet and is trading below tangible book value. The company operates in the oil refining business, which is competiti...

November 4, 2023, 2:40 am

Fibra macquarie: heavily exposed to nearshoring trend

FIBRA Macquarie is a real estate investment trust in Mexico focused on industrial, commercial, and office properties. Mexico's strategic location and ...

November 4, 2023, 1:50 am

Micron is positioned to enjoy the semiconductors next cycle

Micron is an attractive investment opportunity in the information technology sector, operating in the g...

November 4, 2023, 1:39 am

10x genomics: unveiling the investment potential

10x Genomics is a life science technology company with a clear mission and visionary leadership. 10x Genomics delivered a solid Q3 quarter with revenu...

November 4, 2023, 1:02 am

Path final deadline: rosen, national trial lawyers, encourages uipath, inc. investors to secure counsel before important deadline in securities class action – path

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of UiPath, Inc...

November 4, 2023, 1:00 am

Canadian imports softening on lower consumer and business spending

The week ahead will be a lighter one for data releases after signs of decelerating Canadian GDP growth, a higher unemployment rate in both the U.S. an...

November 4, 2023, 12:31 am

Rosen, a leading law firm, encourages pacwest bancorp investors with losses in excess of $100k to secure counsel before important deadline in securities class action – pacw, pacwp

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PacWest Banco...

November 4, 2023, 12:30 am

Otlk investor alert: robbins geller rudman & dowd llp announces that outlook therapeutics, inc. investors with substantial losses have opportunity to lead the outlook therapeutics class action lawsuit

SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that the Outlook Therapeutics class action lawsuit seeks to r...

November 4, 2023, 12:13 am

Canon isn't picture-perfect

Canon has operational advantages in its printing segment and has a strong global presence in various markets. However, the company's financial metrics...

November 4, 2023, 12:12 am

South korea's exports rebound in october 2023

South Korea's exports to mainland China have remained weak during 2023, recording a decline of 9.5% y/y...

November 4, 2023, 12:04 am

Rosen, top ranked investor counsel, encourages tandem diabetes care, inc. investors to secure counsel before important deadline in securities class action – tndm

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabet...

November 4, 2023, 12:00 am

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Usd / cad – canadian dollar counting down to employment reports.

(MENAFN- Baystreet) USD / CAD – Canadian dollar counting down to employment reports. – US NFP expec...

November 3, 2023, 11:29 pm

Rosen, national trial lawyers, encourages purecycle technologies, inc. investors to secure counsel before important deadline in securities class action – pct, pcttw, pcttu

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PureCycle Tec...

November 3, 2023, 11:20 pm


Search within

Pages Search Results: